The Association between Two Common Polymorphisms in MicroRNAs and Hepatocellular Carcinoma Risk in Asian Population

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Hu, Miao ^a   Zhao, Lianying ^b   Hu, Surong ^a   Yang, Jingting ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Kunshan Agency for Public Health Inspection   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 146A; MIR 499; UNCLASSIFIED DRUG;

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MICRORNAS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84874252642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057012     Document Type: Article

References (40)

1. Nguyen MH, Keeffe EB, (2004) Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. Rev Gastroenterol Disord 4 Suppl 1: S14-21.
2. Bouchard MJ, Navas-Martin S, (2011) Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett 305: 123-143.
3. El-Serag HB, Rudolph KL, (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576.
4. El-Serag HB, (2011) Hepatocellular carcinoma. N Engl J Med 365: 1118-1127.
5. Pogribny IP, Rusyn I, (2012) Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett.
6. Hagymasi K, Tulassay Z, (2008) [Epidemiology, risk factors and molecular pathogenesis of primary liver cancer]. Orv Hetil 149: 541-548.
7. Bartel DP, MicroRNAs: genomics, biogenesis, mechanism, and function. [Review] [125 refs]. Cell 116: 281-297.
8. Bartel B, MicroRNAs directing siRNA biogenesis. Nat Struct Mol Biol 12: 569-571.
9. Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, et al. (2008) A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 29: 2126-2131.
10. Zhou J, Lv R, Song X, Li D, Hu X, et al. (2012) Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA Cell Biol 31: 524-530.
11. Kim WH, Min KT, Jeon YJ, Kwon CI, Ko KH, et al. (2012) Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene 504: 92-97.
12. Xiang Y, Fan S, Cao J, Huang S, Zhang LP, (2012) Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep 39: 7019-7023.
13. Akkiz H, Bayram S, Bekar A, Akgollu E, Uskudar O, et al. (2011) No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Gene 486: 104-109.
14. Zhang XW, Pan SD, Feng YL, Liu JB, Dong J, et al. (2011) [Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma]. Zhonghua Yu Fang Yi Xue Za Zhi 45: 239-243.
15. Akkiz H, Bayram S, Bekar A, Akgollu E, Uskudar O, (2011) Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac J Cancer Prev 12: 3107-3112.
16. Lau J, Ioannidis JP, Schmid CH, Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
17. Egger M, Davey Smith G, Schneider M, Minder C, Bias in meta-analysis detected by a simple, graphical test.[see comment]. BMJ 315: 629-634.
18. Law PT, Wong N, (2011) Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroenterol Hepatol 26: 437-449.
19. Liu Z, Li G, Wei S, Niu J, El-Naggar AK, et al. (2010) Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116: 4753-4760.
20. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 105: 7269-7274.
21. Braconi C, Henry JC, Kogure T, Schmittgen T, Patel T, (2011) The role of microRNAs in human liver cancers. Semin Oncol 38: 752-763.
22. Lovat F, Valeri N, Croce CM, MicroRNAs in the Pathogenesis of Cancer. Semin Oncol 38: 724-733.
23. Mittal RD, Gangwar R, George GP, Mittal T, Kapoor R, Investigative Role of Pre-MicroRNAs in Bladder Cancer Patients: A Case-Control Study in North India. DNA Cell Biol 30: 401-406.
24. Pastrello C, Polesel J, Della Puppa L, Viel A, Maestro R, Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis 31: 2124-2126.
25. Srivastava K, Srivastava A, Mittal B, (2010) Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet 55: 495-499.
26. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, et al. (2008) Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27: 5643-5647.
27. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, et al. (2009) Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 69: 1279-1283.
28. Li Y, Vandenboom TG 2nd, Wang Z, Kong D, Ali S, et al. (2010) miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res 70: 1486-1495.
29. Lafferty-Whyte K, Cairney CJ, Jamieson NB, Oien KA, Keith WN, (2009) Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochim Biophys Acta 1792: 341-352.
30. Wang JX, Jiao JQ, Li Q, Long B, Wang K, et al. (2011) miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 17: 71-78.
31. Hu Z, Chen X, Zhao Y, Tian T, Jin G, et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-1726.
32. Wang L, Qian S, Zhi H, Zhang Y, Wang B, et al. (2012) The association between hsa-miR-499 T>C polymorphism and cancer risk: a meta-analysis. Gene 508: 9-14.
33. Wang Y, Yang B, Ren X, (2012) Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-analysis of 17 case-control studies. Gene 509: 267-272.
34. Wang F, Sun G, Zou Y, Li Y, Hao L, et al. (2012) Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls. PLoS One 7: e45042.
35. Wang J, Bi J, Liu X, Li K, Di J, et al. (2012) Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies. Mol Biol Rep 39: 4571-4579.
36. Xu W, Xu J, Liu S, Chen B, Wang X, et al. (2011) Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One 6: e20471.
37. Tian T, Xu Y, Dai J, Wu J, Shen H, et al. (2010) Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-analysis. Int J Mol Epidemiol Genet 1: 358-366.
38. Qiu LX, He J, Wang MY, Zhang RX, Shi TY, et al. (2011) The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine 56: 695-698.
39. Wang J, Wang Q, Liu H, Shao N, Tan B, et al. (2012) The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis 27: 779-788.
40. Wang Z, Cao Y, Jiang C, Yang G, Wu J, et al. (2012) Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis. PLoS One 7: e40039.